Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Polymorphisms of the NADPH Oxidase <i>p22phox</i> Gene in a Caucasian Population with Intracranial Aneurysms
2003
Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease
2001 Standout
An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice
2008
Focal Adhesion Kinase Signaling Regulates Cardiogenesis of Embryonic Stem Cells
2005
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Randomized Comparison of Minimally Invasive Direct Coronary Artery Bypass Surgery Versus Sirolimus-Eluting Stenting in Isolated Proximal Left Anterior Descending Coronary Artery Stenosis
2009
Evolving Therapies for Myocardial Ischemia/Reperfusion Injury
2015
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials
2012
Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics
2007
The pathogenesis of cardiac fibrosis
2013 Standout
TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
2002
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
2002
Magnetofection—A highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo
2003
The Genetic Basis for Cardiomyopathy
2001
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Cardiac hypertrophy and failure: lessons learned from genetically engineered mice
2001
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Mutations of the β myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis
2003
A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery
2007
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1
2012 StandoutNobel
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
2010 Standout
Recent advances into the understanding of mesenchymal stem cell trafficking
2007
MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II
2007
Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy
2009
Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized studies
2010
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
2013 Standout
Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome
2008
NAD(P)H oxidase p22phox Gene C242T polymorphism and lipoprotein oxidation
2003
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy
2001
Hypertrophic Cardiomyopathy
2002 Standout
HIF-1α Activation by Intermittent Hypoxia Requires NADPH Oxidase Stimulation by Xanthine Oxidase
2015 StandoutNobel
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension
2006
The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy
2009
Coronary microvascular endothelial cell growth regulates expression of the gene encoding p22-phox
2005
Isolated Disease of the Proximal Left Anterior Descending Artery
2008
Beneficial Effect of Angiotensin-Blocking Agents on Graft Fibrosis in Hepatitis C Recurrence after Liver Transplantation
2004
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
2010
Adenosine
2014
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
A New Strategy for Discontinuation of Dual Antiplatelet Therapy
2012
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Antioxidants: A Possible Role in Kidney Protection
2003
Lipid oxidation and improving the oxidative stability
2010 Standout
The Role of Hydrogen Peroxide in Endothelial Proliferative Responses
2002
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22phox in lymphoblast cell lines
2002
The failing heart
2002 Nature
NADPH Oxidase-Mediated Oxidative Stress: Genetic Studies of the p22 phox Gene in Hypertension
2005
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Genetic Basis of Thoracic Aortic Aneurysms and Dissections: Focus on Smooth Muscle Cell Contractile Dysfunction
2008
FHL3 binds MyoD and negatively regulates myotube formation
2007
Vascular Superoxide Production by NAD(P)H Oxidase
2000
Relation Between Development of Nephropathy and the p22phox C242T and Receptor for Advanced Glycation End Product G1704T Gene Polymorphisms in Type 2 Diabetic Patients
2004
Chiral Separations
2010
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
2002
Functional Importance of Tyrosine 294 and the Catalytic Selectivity for the Bis-Fe(IV) State of MauG Revealed by Replacement of This Axial Heme Ligand with Histidine,
2010
Longitudinal strain quantitates regional right ventricular contractile function
2003
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
NADPH oxidase promotes NF-κB activation and proliferation in human airway smooth muscle
2002
Cytochromeb558–Dependent NAD(P)H Oxidase–Phox Units in Smooth Muscle and Macrophages of Atherosclerotic Lesions
2002
Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy
2002
Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy
2007
FHL5, a novel actin-binding protein, is highly expressed in eel gill pillar cells and responds to wall tension
2004
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
Biomaterials in cardiac tissue engineering: Ten years of research survey
2008
Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice
2002 StandoutNobel
THE GENETIC BASIS FOR CARDIAC REMODELING
2005
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Differential myocardial gene expression in the development and rescue of murine heart failure
2003
Modifier genes for hypertrophic cardiomyopathy
2002
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis
2000
Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure
2002
Tissue Doppler Imaging Predicts the Development of Hypertrophic Cardiomyopathy in Subjects With Subclinical Disease
2003
Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Conditional Deletion of Focal Adhesion Kinase Leads to Defects in Ventricular Septation and Outflow Tract Alignment
2007 StandoutNobel
C242T CYBA Polymorphism of the NADPH Oxidase Is Associated With Reduced Respiratory Burst in Human Neutrophils
2004
Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography
2004
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
2002
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
2007
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Metal–Organic Frameworks for Separations
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Fhl-1, a New Key Protein in Pulmonary Hypertension
2008
Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis
2017
Functional effects of NAD(P)H oxidase p22phox C242T mutation in human leukocytes and association with thrombotic cerebral infarction
2004
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
2006 StandoutScience
Association of NAD(P)H Oxidase p22 phox Gene Variation With Advanced Carotid Atherosclerosis in Japanese Type 2 Diabetes
2003
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Disease Pathways and Novel Therapeutic Targets in Hypertrophic Cardiomyopathy
2011
Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management
2001
Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States
2005 Standout
Common Genomic Response in Different Mouse Models of β-Adrenergic–Induced Cardiomyopathy
2003
Prevention of Cardiac Hypertrophy by Atorvastatin in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy
2005
Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy
2001
Works of Do‐Sun Lim being referenced
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention
2013
Stenting or MIDCAB using ministernotomy for revascularization of proximal left anterior descending artery?
2005
Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes
2001
A transgenic rabbit model for human hypertrophic cardiomyopathy
1999
Variants of Trophic Factors and Expression of Cardiac Hypertrophy in Patients with Hypertrophic Cardiomyopathy
2000
Comparison of three‐year clinical outcomes between sirolimus‐versus paclitaxel‐eluting stents in diabetic patients: Prospective randomized multicenter trial
2009
5-azacytidine induces cardiac differentiation of P19 embryonic stem cells
2004
Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial
2008
Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model
2005
Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis
2004
Tissue Doppler Imaging Consistently Detects Myocardial Contraction and Relaxation Abnormalities, Irrespective of Cardiac Hypertrophy, in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy
2000
A Variant of p22 phox , Involved in Generation of Reactive Oxygen Species in the Vessel Wall, Is Associated With Progression of Coronary Atherosclerosis
2000
Three-Month Dual Antiplatelet Therapy After Implantation of Zotarolimus-Eluting Stents - The DATE (Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent) Registry -
2010
Angiotensin II Blockade Reverses Myocardial Fibrosis in a Transgenic Mouse Model of Human Hypertrophic Cardiomyopathy
2001